- Home
- PED vs GNTA Comparison
PED vs GNTA Comparison
Compare PED & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- GNTA
- Stock Information
- Founded
- PED N/A
- GNTA 2014
- Country
- PED United States
- GNTA Italy
- Employees
- PED N/A
- GNTA N/A
- Industry
- PED Oil & Gas Production
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PED Energy
- GNTA Health Care
- Exchange
- PED Nasdaq
- GNTA Nasdaq
- Market Cap
- PED 48.8M
- GNTA 81.2M
- IPO Year
- PED N/A
- GNTA 2021
- Fundamental
- Price
- PED $0.65
- GNTA $3.05
- Analyst Decision
- PED Strong Buy
- GNTA Strong Buy
- Analyst Count
- PED 2
- GNTA 1
- Target Price
- PED $1.63
- GNTA $25.00
- AVG Volume (30 Days)
- PED 565.0K
- GNTA 11.1K
- Earning Date
- PED 08-13-2025
- GNTA 01-01-0001
- Dividend Yield
- PED N/A
- GNTA N/A
- EPS Growth
- PED 2248.88
- GNTA N/A
- EPS
- PED 0.19
- GNTA N/A
- Revenue
- PED $40,173,000.00
- GNTA N/A
- Revenue This Year
- PED N/A
- GNTA N/A
- Revenue Next Year
- PED $5.99
- GNTA N/A
- P/E Ratio
- PED $3.42
- GNTA N/A
- Revenue Growth
- PED 30.70
- GNTA N/A
- 52 Week Low
- PED $0.47
- GNTA $2.79
- 52 Week High
- PED $1.10
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- PED 48.64
- GNTA 37.03
- Support Level
- PED $0.64
- GNTA $2.90
- Resistance Level
- PED $0.81
- GNTA $3.39
- Average True Range (ATR)
- PED 0.05
- GNTA 0.15
- MACD
- PED -0.01
- GNTA -0.04
- Stochastic Oscillator
- PED 12.81
- GNTA 34.82
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.